Headlines

The catastrophic events on September 11, 2001, left behind a tragedy with no easy answers. Since then, the families of those killed and victims injured in the attacks have fought the good fight in pursuit of truth and justice. On August 28, 2025, District Judge George Daniels of the Southern District of New York…

The August 28, 2025, ruling by U.S. District Judge George Daniels found that the plaintiffs’ claims were sufficiently strong to proceed and rejected the Kingdom of Saudi Arabia argument that its alleged ties to the attackers were coincidental and innocent.

Motley Rice member Mike Daly was appointed to the Board of Directors for the Philadelphia Trial Lawyers Association (PTLA).

Motley Rice LLC welcomed nine talented law students all representing different law schools for its 2025 summer law clerk program.

Chambers USA released its annual rankings and has listed both Motley Rice’s securities fraud and product liability practices as nationally ranked – their highest ranking.

Glyphosate bans have been enacted in several U.S. cities and foreign countries due to health concerns.

Motley Rice welcomes Joshua M. Neuman as senior counsel and Josey M. Richards and Alexandra A. Stulpin joined as associates at Three Logan Square in Philadelphia.

Sarah Wynn-Williams—Meta whistleblower and author of the recently released book “Careless People”—testified before the U.S. Senate April 9 about many of the company’s negative business practices.

Jazz Pharmaceuticals has agreed to pay $145 million to resolve antitrust litigation alleging pay-for-delay tactics with popular narcolepsy drug Xyrem®.

Our client lost their livelihood after being diagnosed with nonarteritic anterior ischemic optic neuropathy (NAION). Despite stopping Ozempic, they remain legally blind.